Akt1-IN-8
Product Specifications
CAS Number
2247688-87-3
Target
Akt
Related Pathways
Cytoskeletal Signaling, PI3K/Akt/mTOR signaling
Bioactivity
Akt1-IN-8 (Compound JL18) is a potent AKT1 kinase inhibitor with oral bioavailability of 41% and an IC50 value of 8.8 nM. It exhibits significant antiproliferative effects against PC-3 prostate cancer cells, with an IC50 of 3.0 μM. Akt1-IN-8 also reduces phosphorylated GSK3β levels.
Smiles
O=C(N1CCN(C=2N=CN=C3NN=C(Br)C32)CC1)C(C4=CC=C(Br)C=C4)CNC(C)C
Molecular Formula
C21H25Br2N7O
Molecular Weight
551.278
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
